Inventor · disambiguated record
Se Eun Byeon
Also filed as: BYEON SE EUN
5 granted patents·1 pending application·0 citations·filing 2014–2023
60Inventor score
Top patents by PatentIndex Score
6 records- 0168US11793862B2Pharmaceutical composition for treating non-alcoholic fatty liver, non-alcoholic steatohepatitis, or hepatic fibrosis using Ssu72 protein or a polynucleotide encoding the sameCUROGEN TECH CO LTD·Filed 2022·Granted Oct 24, 2023·0 cites·24 claims
- 0267US2024075110A1Pharmaceutical composition for treating non-alcoholic fatty liver, non-alcoholic steatohepatitis, or hepatic fibrosis using ssu72 protein or a polynucleotide encoding the sameCUROGEN TECH CO LTD·Filed 2023·Application pending·0 cites
- 0354US12188026B2Surface expression vector using poly-gamma-glutamate synthetic gene derived from strain in Bacillus, and method for expressing protein on surface of microorganism, using sameBIOLEADERS CORP·Filed 2019·Granted Jan 7, 2025·0 cites·14 claims
- 0449US12180469B2Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from Lactobacillus casei, and use thereofBIOLEADERS CORP·Filed 2019·Granted Dec 31, 2024·0 cites·14 claims
- 0547US9566304B2Pharmaceutical composition for preventing or treating cancers comprising dendritic cells with Dab2 gene silencedUNIV SUNGKYUNKWAN RES & BUS·Filed 2014·Granted Feb 14, 2017·0 cites·8 claims
- 0646US12188027B2Surface expression vector using two kinds of promoters derived from Lactobacillus casei for concurrently expressing two target proteins and method for expressing proteins on microbial surface by using sameBIOLEADERS CORP·Filed 2019·Granted Jan 7, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Se Eun Byeon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →